Last 12 months
Inside the activity.
0 purchase rows · 2 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 1 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 1 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 27, 2020 Filed Aug 31, 2020 21:16 UTC | SaleCommon Stock | 150,131 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-20-100861 · tm2029863d3_4.xml · nonDerivative · entry 1 Gulf Hungary Holding Korlatolt Felelossegu Tarsasag · CIK 0001783455 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 219,367 F1 · kind: Transfer by the reporting person to QH Hungary Holdings Limited, a wholly owned subsidiary of the reporting person ("QH Hungary"). F1 · price: Transfer by the reporting person to QH Hungary Holdings Limited, a wholly owned subsidiary of the reporting person ("QH Hungary"). Read SEC document |
|
| August 27, 2020 Filed Aug 31, 2020 21:16 UTC |
QH Hungary Holdings Ltd10% owner
|
OtherPrepaid Variable Forward Sale Contract · Derivative | 60,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-20-100860 · tm2029863d2_4.xml · derivative · entry 3 QH Hungary Holdings Ltd · CIK 0001808660 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,000 Underlying: Common Stock · 60,000 shares Expires not disclosed F3 · derivative.exercise_price: On August 27, 2020, the Reporting Person entered into a prepaid variable share forward transaction with Citibank, N.A. ("Citibank"). See Footnote 4 and Remarks for details of the transaction. F4 · derivative.exercise_price: The prepaid forward transactions with JPMorgan and Citibank are each divided into 14 components (each a "Component"). For each Component, the reporting person is obligated to, on the settlement date (the "Settlement Date") determined based on the specified scheduled valuation date within the period from August 18, 2022 to September 7, 2022, either, at the reporting person's option, (i) up to 10,000 Shares to JPMorgan and up to 4,286 Shares (or 4,282 Shares for the last Settlement Date) to Citi (such Share number, "Subject Number") based on the average market price of the Shares determined as described below in Remarks or (ii) an amount of cash equivalent to the value of such Shares. In exchange for assuming the obligation under each contract, the reporting person received an upfront cash prepayment of $9,481,130.00 and $22,122,636.00 from Citibank and JPMorgan, respectively. F3 · kind: On August 27, 2020, the Reporting Person entered into a prepaid variable share forward transaction with Citibank, N.A. ("Citibank"). See Footnote 4 and Remarks for details of the transaction. F4 · kind: The prepaid forward transactions with JPMorgan and Citibank are each divided into 14 components (each a "Component"). For each Component, the reporting person is obligated to, on the settlement date (the "Settlement Date") determined based on the specified scheduled valuation date within the period from August 18, 2022 to September 7, 2022, either, at the reporting person's option, (i) up to 10,000 Shares to JPMorgan and up to 4,286 Shares (or 4,282 Shares for the last Settlement Date) to Citi (such Share number, "Subject Number") based on the average market price of the Shares determined as described below in Remarks or (ii) an amount of cash equivalent to the value of such Shares. In exchange for assuming the obligation under each contract, the reporting person received an upfront cash prepayment of $9,481,130.00 and $22,122,636.00 from Citibank and JPMorgan, respectively. F3 · price: On August 27, 2020, the Reporting Person entered into a prepaid variable share forward transaction with Citibank, N.A. ("Citibank"). See Footnote 4 and Remarks for details of the transaction. F4 · price: The prepaid forward transactions with JPMorgan and Citibank are each divided into 14 components (each a "Component"). For each Component, the reporting person is obligated to, on the settlement date (the "Settlement Date") determined based on the specified scheduled valuation date within the period from August 18, 2022 to September 7, 2022, either, at the reporting person's option, (i) up to 10,000 Shares to JPMorgan and up to 4,286 Shares (or 4,282 Shares for the last Settlement Date) to Citi (such Share number, "Subject Number") based on the average market price of the Shares determined as described below in Remarks or (ii) an amount of cash equivalent to the value of such Shares. In exchange for assuming the obligation under each contract, the reporting person received an upfront cash prepayment of $9,481,130.00 and $22,122,636.00 from Citibank and JPMorgan, respectively. F3 · derivative.exercise_date: On August 27, 2020, the Reporting Person entered into a prepaid variable share forward transaction with Citibank, N.A. ("Citibank"). See Footnote 4 and Remarks for details of the transaction. F4 · derivative.exercise_date: The prepaid forward transactions with JPMorgan and Citibank are each divided into 14 components (each a "Component"). For each Component, the reporting person is obligated to, on the settlement date (the "Settlement Date") determined based on the specified scheduled valuation date within the period from August 18, 2022 to September 7, 2022, either, at the reporting person's option, (i) up to 10,000 Shares to JPMorgan and up to 4,286 Shares (or 4,282 Shares for the last Settlement Date) to Citi (such Share number, "Subject Number") based on the average market price of the Shares determined as described below in Remarks or (ii) an amount of cash equivalent to the value of such Shares. In exchange for assuming the obligation under each contract, the reporting person received an upfront cash prepayment of $9,481,130.00 and $22,122,636.00 from Citibank and JPMorgan, respectively. F3 · derivative.expiration_date: On August 27, 2020, the Reporting Person entered into a prepaid variable share forward transaction with Citibank, N.A. ("Citibank"). See Footnote 4 and Remarks for details of the transaction. F4 · derivative.expiration_date: The prepaid forward transactions with JPMorgan and Citibank are each divided into 14 components (each a "Component"). For each Component, the reporting person is obligated to, on the settlement date (the "Settlement Date") determined based on the specified scheduled valuation date within the period from August 18, 2022 to September 7, 2022, either, at the reporting person's option, (i) up to 10,000 Shares to JPMorgan and up to 4,286 Shares (or 4,282 Shares for the last Settlement Date) to Citi (such Share number, "Subject Number") based on the average market price of the Shares determined as described below in Remarks or (ii) an amount of cash equivalent to the value of such Shares. In exchange for assuming the obligation under each contract, the reporting person received an upfront cash prepayment of $9,481,130.00 and $22,122,636.00 from Citibank and JPMorgan, respectively. Read SEC document |
| August 27, 2020 Filed Aug 31, 2020 21:16 UTC |
QH Hungary Holdings Ltd10% owner
|
OtherPrepaid Variable Forward Sale Contract · Derivative | 140,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-20-100860 · tm2029863d2_4.xml · derivative · entry 2 QH Hungary Holdings Ltd · CIK 0001808660 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 140,000 Underlying: Common Stock · 140,000 shares Expires not disclosed F2 · derivative.exercise_price: On August 27, 2020, the Reporting Person entered into a prepaid variable share forward transaction with JPMorgan Chase Bank, National Association ("JPMorgan"). See Footnote 4 and Remarks for details of the transaction. F4 · derivative.exercise_price: The prepaid forward transactions with JPMorgan and Citibank are each divided into 14 components (each a "Component"). For each Component, the reporting person is obligated to, on the settlement date (the "Settlement Date") determined based on the specified scheduled valuation date within the period from August 18, 2022 to September 7, 2022, either, at the reporting person's option, (i) up to 10,000 Shares to JPMorgan and up to 4,286 Shares (or 4,282 Shares for the last Settlement Date) to Citi (such Share number, "Subject Number") based on the average market price of the Shares determined as described below in Remarks or (ii) an amount of cash equivalent to the value of such Shares. In exchange for assuming the obligation under each contract, the reporting person received an upfront cash prepayment of $9,481,130.00 and $22,122,636.00 from Citibank and JPMorgan, respectively. F2 · kind: On August 27, 2020, the Reporting Person entered into a prepaid variable share forward transaction with JPMorgan Chase Bank, National Association ("JPMorgan"). See Footnote 4 and Remarks for details of the transaction. F4 · kind: The prepaid forward transactions with JPMorgan and Citibank are each divided into 14 components (each a "Component"). For each Component, the reporting person is obligated to, on the settlement date (the "Settlement Date") determined based on the specified scheduled valuation date within the period from August 18, 2022 to September 7, 2022, either, at the reporting person's option, (i) up to 10,000 Shares to JPMorgan and up to 4,286 Shares (or 4,282 Shares for the last Settlement Date) to Citi (such Share number, "Subject Number") based on the average market price of the Shares determined as described below in Remarks or (ii) an amount of cash equivalent to the value of such Shares. In exchange for assuming the obligation under each contract, the reporting person received an upfront cash prepayment of $9,481,130.00 and $22,122,636.00 from Citibank and JPMorgan, respectively. F2 · price: On August 27, 2020, the Reporting Person entered into a prepaid variable share forward transaction with JPMorgan Chase Bank, National Association ("JPMorgan"). See Footnote 4 and Remarks for details of the transaction. F4 · price: The prepaid forward transactions with JPMorgan and Citibank are each divided into 14 components (each a "Component"). For each Component, the reporting person is obligated to, on the settlement date (the "Settlement Date") determined based on the specified scheduled valuation date within the period from August 18, 2022 to September 7, 2022, either, at the reporting person's option, (i) up to 10,000 Shares to JPMorgan and up to 4,286 Shares (or 4,282 Shares for the last Settlement Date) to Citi (such Share number, "Subject Number") based on the average market price of the Shares determined as described below in Remarks or (ii) an amount of cash equivalent to the value of such Shares. In exchange for assuming the obligation under each contract, the reporting person received an upfront cash prepayment of $9,481,130.00 and $22,122,636.00 from Citibank and JPMorgan, respectively. F2 · derivative.exercise_date: On August 27, 2020, the Reporting Person entered into a prepaid variable share forward transaction with JPMorgan Chase Bank, National Association ("JPMorgan"). See Footnote 4 and Remarks for details of the transaction. F4 · derivative.exercise_date: The prepaid forward transactions with JPMorgan and Citibank are each divided into 14 components (each a "Component"). For each Component, the reporting person is obligated to, on the settlement date (the "Settlement Date") determined based on the specified scheduled valuation date within the period from August 18, 2022 to September 7, 2022, either, at the reporting person's option, (i) up to 10,000 Shares to JPMorgan and up to 4,286 Shares (or 4,282 Shares for the last Settlement Date) to Citi (such Share number, "Subject Number") based on the average market price of the Shares determined as described below in Remarks or (ii) an amount of cash equivalent to the value of such Shares. In exchange for assuming the obligation under each contract, the reporting person received an upfront cash prepayment of $9,481,130.00 and $22,122,636.00 from Citibank and JPMorgan, respectively. F2 · derivative.expiration_date: On August 27, 2020, the Reporting Person entered into a prepaid variable share forward transaction with JPMorgan Chase Bank, National Association ("JPMorgan"). See Footnote 4 and Remarks for details of the transaction. F4 · derivative.expiration_date: The prepaid forward transactions with JPMorgan and Citibank are each divided into 14 components (each a "Component"). For each Component, the reporting person is obligated to, on the settlement date (the "Settlement Date") determined based on the specified scheduled valuation date within the period from August 18, 2022 to September 7, 2022, either, at the reporting person's option, (i) up to 10,000 Shares to JPMorgan and up to 4,286 Shares (or 4,282 Shares for the last Settlement Date) to Citi (such Share number, "Subject Number") based on the average market price of the Shares determined as described below in Remarks or (ii) an amount of cash equivalent to the value of such Shares. In exchange for assuming the obligation under each contract, the reporting person received an upfront cash prepayment of $9,481,130.00 and $22,122,636.00 from Citibank and JPMorgan, respectively. Read SEC document |
| August 27, 2020 Filed Aug 31, 2020 21:16 UTC |
QH Hungary Holdings Ltd10% owner
|
PurchaseCommon Stock | 150,131 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-20-100860 · tm2029863d2_4.xml · nonDerivative · entry 1 QH Hungary Holdings Ltd · CIK 0001808660 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,054,584 F1 · kind: Transfer by Gulf Hungary Holding Korlatolt Felelossegu Tarsasag ("Gulf Hungary"), parent company of the Reporting Person, to the Reporting Person. F1 · price: Transfer by Gulf Hungary Holding Korlatolt Felelossegu Tarsasag ("Gulf Hungary"), parent company of the Reporting Person, to the Reporting Person. Read SEC document |
| August 14, 2020 Filed Aug 17, 2020 20:16 UTC |
PLATZER L WILBERTSVP, Global Ops, EHS & Prcmt
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 417 | $0.00 Strike: $154.92 | $0.00 |
DisclosureSEC source: 0001209191-20-046940 · doc4.xml · derivative · entry 21 PLATZER L WILBERT · CIK 0001242086 · SVP, Global Ops, EHS & Prcmt 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,684 Underlying: Common Stock · 417 shares Expires 2026-02-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F12 · derivative.exercise_date: The options for this grant vest in three annual installments: 842 shares on February 25, 2020; 842 shares on February 25, 2021; and 842 shares on February 25, 2022. Read SEC document |
| August 14, 2020 Filed Aug 17, 2020 20:16 UTC |
PLATZER L WILBERTSVP, Global Ops, EHS & Prcmt
|
SaleCommon Stock | 12 | $198.99 | $2,387.88 |
DisclosureSEC source: 0001209191-20-046940 · doc4.xml · nonDerivative · entry 16 PLATZER L WILBERT · CIK 0001242086 · SVP, Global Ops, EHS & Prcmt 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,991 F8 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $198.95 to $199.03, inclusive. The reporting person undertakes to provide to Quaker Chemical Corporation, d/b/a "Quaker Houghton", any security holder of Quaker Houghton, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (8) to this Form 4. Read SEC document |
| August 14, 2020 Filed Aug 17, 2020 20:16 UTC |
PLATZER L WILBERTSVP, Global Ops, EHS & Prcmt
|
SaleCommon Stock | 170 | $198.39 | $33,726.30 |
DisclosureSEC source: 0001209191-20-046940 · doc4.xml · nonDerivative · entry 15 PLATZER L WILBERT · CIK 0001242086 · SVP, Global Ops, EHS & Prcmt 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,003 F7 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $197.94 to $198.87, inclusive. The reporting person undertakes to provide to Quaker Chemical Corporation, d/b/a "Quaker Houghton", any security holder of Quaker Houghton, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (7) to this Form 4. Read SEC document |
| August 14, 2020 Filed Aug 17, 2020 20:16 UTC |
PLATZER L WILBERTSVP, Global Ops, EHS & Prcmt
|
SaleCommon Stock | 135 | $197.31 | $26,636.85 |
DisclosureSEC source: 0001209191-20-046940 · doc4.xml · nonDerivative · entry 14 PLATZER L WILBERT · CIK 0001242086 · SVP, Global Ops, EHS & Prcmt 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,173 F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $196.91 to $197.84, inclusive. The reporting person undertakes to provide to Quaker Chemical Corporation, d/b/a "Quaker Houghton", any security holder of Quaker Houghton, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (6) to this Form 4. Read SEC document |
| August 14, 2020 Filed Aug 17, 2020 20:16 UTC |
PLATZER L WILBERTSVP, Global Ops, EHS & Prcmt
|
SaleCommon Stock | 36 | $196.26 | $7,065.36 |
DisclosureSEC source: 0001209191-20-046940 · doc4.xml · nonDerivative · entry 13 PLATZER L WILBERT · CIK 0001242086 · SVP, Global Ops, EHS & Prcmt 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,308 F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $195.81 to $196.70, inclusive. The reporting person undertakes to provide to Quaker Chemical Corporation, d/b/a "Quaker Houghton", any security holder of Quaker Houghton, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (5) to this Form 4. Read SEC document |
| August 14, 2020 Filed Aug 17, 2020 20:16 UTC |
PLATZER L WILBERTSVP, Global Ops, EHS & Prcmt
|
SaleCommon Stock | 64 | $195.06 | $12,483.84 |
DisclosureSEC source: 0001209191-20-046940 · doc4.xml · nonDerivative · entry 12 PLATZER L WILBERT · CIK 0001242086 · SVP, Global Ops, EHS & Prcmt 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,344 F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $194.66 to $195.60, inclusive. The reporting person undertakes to provide to Quaker Chemical Corporation, d/b/a "Quaker Houghton", any security holder of Quaker Houghton, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (4) to this Form 4. Read SEC document |
| August 14, 2020 Filed Aug 17, 2020 20:16 UTC |
PLATZER L WILBERTSVP, Global Ops, EHS & Prcmt
|
Exercise / conversionCommon Stock | 417 | $154.92 | $64,601.64 |
DisclosureSEC source: 0001209191-20-046940 · doc4.xml · nonDerivative · entry 11 PLATZER L WILBERT · CIK 0001242086 · SVP, Global Ops, EHS & Prcmt 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,408 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 13, 2020 Filed Aug 17, 2020 20:16 UTC |
PLATZER L WILBERTSVP, Global Ops, EHS & Prcmt
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 425 | $0.00 Strike: $154.92 | $0.00 |
DisclosureSEC source: 0001209191-20-046940 · doc4.xml · derivative · entry 20 PLATZER L WILBERT · CIK 0001242086 · SVP, Global Ops, EHS & Prcmt 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,101 Underlying: Common Stock · 425 shares Expires 2026-02-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F12 · derivative.exercise_date: The options for this grant vest in three annual installments: 842 shares on February 25, 2020; 842 shares on February 25, 2021; and 842 shares on February 25, 2022. Read SEC document |
| August 13, 2020 Filed Aug 17, 2020 20:16 UTC |
PLATZER L WILBERTSVP, Global Ops, EHS & Prcmt
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 1,228 | $0.00 Strike: $151.75 | $0.00 |
DisclosureSEC source: 0001209191-20-046940 · doc4.xml · derivative · entry 19 PLATZER L WILBERT · CIK 0001242086 · SVP, Global Ops, EHS & Prcmt 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 613 Underlying: Common Stock · 1,228 shares Expires 2025-02-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F11 · derivative.exercise_date: The options for this grant vest in three annual installments: 614 shares on February 26, 2019; 614 shares on February 26, 2020; and 613 shares on February 26, 2021. Read SEC document |
| August 13, 2020 Filed Aug 17, 2020 20:16 UTC |
PLATZER L WILBERTSVP, Global Ops, EHS & Prcmt
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 2,188 | $0.00 Strike: $134.60 | $0.00 |
DisclosureSEC source: 0001209191-20-046940 · doc4.xml · derivative · entry 18 PLATZER L WILBERT · CIK 0001242086 · SVP, Global Ops, EHS & Prcmt 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,188 shares Expires 2024-02-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F10 · derivative.exercise_date: The options for this grant vested in three annual installments: 730 shares on February 27, 2018; 729 shares on February 27, 2019; and 729 shares on February 27, 2020. Read SEC document |
| August 13, 2020 Filed Aug 17, 2020 20:16 UTC |
PLATZER L WILBERTSVP, Global Ops, EHS & Prcmt
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 1,213 | $0.00 Strike: $72.12 | $0.00 |
DisclosureSEC source: 0001209191-20-046940 · doc4.xml · derivative · entry 17 PLATZER L WILBERT · CIK 0001242086 · SVP, Global Ops, EHS & Prcmt 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,213 shares Expires 2023-02-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F9 · derivative.exercise_date: The options for this grant vested in three annual installments: 1,213 shares on February 23, 2017; 1,213 shares on February 23, 2018; and 1,213 shares on February 23, 2019. Read SEC document |
| August 13, 2020 Filed Aug 17, 2020 20:16 UTC |
PLATZER L WILBERTSVP, Global Ops, EHS & Prcmt
|
SaleCommon Stock | 400 | $197.39 | $78,956.00 |
DisclosureSEC source: 0001209191-20-046940 · doc4.xml · nonDerivative · entry 10 PLATZER L WILBERT · CIK 0001242086 · SVP, Global Ops, EHS & Prcmt 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,991 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $197.05 to $197.65, inclusive. The reporting person undertakes to provide to Quaker Chemical Corporation, d/b/a "Quaker Houghton", any security holder of Quaker Houghton, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (3) to this Form 4. Read SEC document |
| August 13, 2020 Filed Aug 17, 2020 20:16 UTC |
PLATZER L WILBERTSVP, Global Ops, EHS & Prcmt
|
SaleCommon Stock | 25 | $196.12 | $4,903.00 |
DisclosureSEC source: 0001209191-20-046940 · doc4.xml · nonDerivative · entry 9 PLATZER L WILBERT · CIK 0001242086 · SVP, Global Ops, EHS & Prcmt 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,391 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $196.00 to $196.98, inclusive. The reporting person undertakes to provide to Quaker Chemical Corporation, d/b/a "Quaker Houghton", any security holder of Quaker Houghton, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4. Read SEC document |
| August 13, 2020 Filed Aug 17, 2020 20:16 UTC |
PLATZER L WILBERTSVP, Global Ops, EHS & Prcmt
|
Exercise / conversionCommon Stock | 425 | $154.92 | $65,841.00 |
DisclosureSEC source: 0001209191-20-046940 · doc4.xml · nonDerivative · entry 8 PLATZER L WILBERT · CIK 0001242086 · SVP, Global Ops, EHS & Prcmt 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,416 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 13, 2020 Filed Aug 17, 2020 20:16 UTC |
PLATZER L WILBERTSVP, Global Ops, EHS & Prcmt
|
SaleCommon Stock | 1,228 | $196.12 | $240,835.36 |
DisclosureSEC source: 0001209191-20-046940 · doc4.xml · nonDerivative · entry 7 PLATZER L WILBERT · CIK 0001242086 · SVP, Global Ops, EHS & Prcmt 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,991 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $196.00 to $196.98, inclusive. The reporting person undertakes to provide to Quaker Chemical Corporation, d/b/a "Quaker Houghton", any security holder of Quaker Houghton, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4. Read SEC document |
| August 13, 2020 Filed Aug 17, 2020 20:16 UTC |
PLATZER L WILBERTSVP, Global Ops, EHS & Prcmt
|
Exercise / conversionCommon Stock | 1,228 | $151.75 | $186,349.00 |
DisclosureSEC source: 0001209191-20-046940 · doc4.xml · nonDerivative · entry 6 PLATZER L WILBERT · CIK 0001242086 · SVP, Global Ops, EHS & Prcmt 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,219 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 13, 2020 Filed Aug 17, 2020 20:16 UTC |
PLATZER L WILBERTSVP, Global Ops, EHS & Prcmt
|
SaleCommon Stock | 2,188 | $196.12 | $429,110.56 |
DisclosureSEC source: 0001209191-20-046940 · doc4.xml · nonDerivative · entry 5 PLATZER L WILBERT · CIK 0001242086 · SVP, Global Ops, EHS & Prcmt 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,991 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $196.00 to $196.98, inclusive. The reporting person undertakes to provide to Quaker Chemical Corporation, d/b/a "Quaker Houghton", any security holder of Quaker Houghton, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4. Read SEC document |
| August 13, 2020 Filed Aug 17, 2020 20:16 UTC |
PLATZER L WILBERTSVP, Global Ops, EHS & Prcmt
|
Exercise / conversionCommon Stock | 2,188 | $134.60 | $294,504.80 |
DisclosureSEC source: 0001209191-20-046940 · doc4.xml · nonDerivative · entry 4 PLATZER L WILBERT · CIK 0001242086 · SVP, Global Ops, EHS & Prcmt 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,179 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 13, 2020 Filed Aug 17, 2020 20:16 UTC |
PLATZER L WILBERTSVP, Global Ops, EHS & Prcmt
|
SaleCommon Stock | 1,213 | $196.12 | $237,893.56 |
DisclosureSEC source: 0001209191-20-046940 · doc4.xml · nonDerivative · entry 3 PLATZER L WILBERT · CIK 0001242086 · SVP, Global Ops, EHS & Prcmt 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,991 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $196.00 to $196.98, inclusive. The reporting person undertakes to provide to Quaker Chemical Corporation, d/b/a "Quaker Houghton", any security holder of Quaker Houghton, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4. Read SEC document |
| August 13, 2020 Filed Aug 17, 2020 20:16 UTC |
PLATZER L WILBERTSVP, Global Ops, EHS & Prcmt
|
Exercise / conversionCommon Stock | 1,213 | $72.12 | $87,481.56 |
DisclosureSEC source: 0001209191-20-046940 · doc4.xml · nonDerivative · entry 2 PLATZER L WILBERT · CIK 0001242086 · SVP, Global Ops, EHS & Prcmt 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,204 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 13, 2020 Filed Aug 17, 2020 20:16 UTC |
PLATZER L WILBERTSVP, Global Ops, EHS & Prcmt
|
SaleCommon Stock | 500 | $199.10 | $99,547.50 |
DisclosureSEC source: 0001209191-20-046940 · doc4.xml · nonDerivative · entry 1 PLATZER L WILBERT · CIK 0001242086 · SVP, Global Ops, EHS & Prcmt 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,991 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $198.82 to $199.26, inclusive. The reporting person undertakes to provide to Quaker Chemical Corporation, d/b/a "Quaker Houghton", any security holder of Quaker Houghton, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4. Read SEC document |
| August 12, 2020 Filed Aug 13, 2020 20:21 UTC |
STEEPLES ADRIANSVP, Managing Director - EMEA
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 2,188 | $0.00 Strike: $134.60 | $0.00 |
DisclosureSEC source: 0001209191-20-046603 · doc4.xml · derivative · entry 5 STEEPLES ADRIAN · CIK 0001580051 · SVP, Managing Director - EMEA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,188 shares Expires 2024-02-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The options for this grant vested in three annual installments: 730 shares on February 27, 2018; 729 shares on February 27, 2019; and 729 shares on February 27, 2020. Read SEC document |
| August 12, 2020 Filed Aug 13, 2020 20:21 UTC |
STEEPLES ADRIANSVP, Managing Director - EMEA
|
SaleCommon Stock | 700 | $202.74 | $141,918.00 |
DisclosureSEC source: 0001209191-20-046603 · doc4.xml · nonDerivative · entry 4 STEEPLES ADRIAN · CIK 0001580051 · SVP, Managing Director - EMEA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,475 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $202.57 to $202.93, inclusive. The reporting person undertakes to provide to Quaker Chemical Corporation, d/b/a "Quaker Houghton", any security holder of Quaker Houghton, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (3) to this Form 4. Read SEC document |
| August 12, 2020 Filed Aug 13, 2020 20:21 UTC |
STEEPLES ADRIANSVP, Managing Director - EMEA
|
SaleCommon Stock | 1,300 | $201.65 | $262,145.00 |
DisclosureSEC source: 0001209191-20-046603 · doc4.xml · nonDerivative · entry 3 STEEPLES ADRIAN · CIK 0001580051 · SVP, Managing Director - EMEA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,175 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $201.20 to $202.14, inclusive. The reporting person undertakes to provide to Quaker Chemical Corporation, d/b/a "Quaker Houghton", any security holder of Quaker Houghton, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4. Read SEC document |
| August 12, 2020 Filed Aug 13, 2020 20:21 UTC |
STEEPLES ADRIANSVP, Managing Director - EMEA
|
SaleCommon Stock | 188 | $200.64 | $37,720.32 |
DisclosureSEC source: 0001209191-20-046603 · doc4.xml · nonDerivative · entry 2 STEEPLES ADRIAN · CIK 0001580051 · SVP, Managing Director - EMEA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,475 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $200.13 to $200.80, inclusive. The reporting person undertakes to provide to Quaker Chemical Corporation, d/b/a "Quaker Houghton", any security holder of Quaker Houghton, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4. Read SEC document |
| August 12, 2020 Filed Aug 13, 2020 20:21 UTC |
STEEPLES ADRIANSVP, Managing Director - EMEA
|
Exercise / conversionCommon Stock | 2,188 | $134.60 | $294,504.80 |
DisclosureSEC source: 0001209191-20-046603 · doc4.xml · nonDerivative · entry 1 STEEPLES ADRIAN · CIK 0001580051 · SVP, Managing Director - EMEA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,663 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 11, 2020 Filed Aug 12, 2020 20:34 UTC |
DOUGLAS MARKDirector
|
SaleCommon Stock | 1,275 | $201.88 | $257,394.45 |
DisclosureSEC source: 0001209191-20-046381 · doc4.xml · nonDerivative · entry 1 DOUGLAS MARK · CIK 0001434812 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,008 Read SEC document |
| August 11, 2020 Filed Aug 12, 2020 20:30 UTC |
BERQUIST JOSEPH ASVP, GL SPEC BUS & CSO
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 1,660 | $0.00 Strike: $151.75 | $0.00 |
DisclosureSEC source: 0001209191-20-046372 · doc4.xml · derivative · entry 9 BERQUIST JOSEPH A · CIK 0001487224 · SVP, GL SPEC BUS & CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 830 Underlying: Common Stock · 1,660 shares Expires 2025-02-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: The options for this grant vest in three annual installments: 830 shares on February 26, 2019; 830 shares on February 26, 2020; and 830 shares on February 26, 2021. Read SEC document |
| August 11, 2020 Filed Aug 12, 2020 20:30 UTC |
BERQUIST JOSEPH ASVP, GL SPEC BUS & CSO
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 2,188 | $0.00 Strike: $134.60 | $0.00 |
DisclosureSEC source: 0001209191-20-046372 · doc4.xml · derivative · entry 8 BERQUIST JOSEPH A · CIK 0001487224 · SVP, GL SPEC BUS & CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,188 shares Expires 2024-02-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: The options for this grant vested in three annual installments: 730 shares on February 27, 2018; 729 shares on February 27, 2019; and 729 shares on February 27, 2020. Read SEC document |
| August 11, 2020 Filed Aug 12, 2020 20:30 UTC |
BERQUIST JOSEPH ASVP, GL SPEC BUS & CSO
|
SaleCommon Stock | 472 | $202.68 | $95,664.96 |
DisclosureSEC source: 0001209191-20-046372 · doc4.xml · nonDerivative · entry 6 BERQUIST JOSEPH A · CIK 0001487224 · SVP, GL SPEC BUS & CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,515 F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $202.41 to $203.085, inclusive. The reporting person undertakes to provide to Quaker Chemical Corporation, d/b/a "Quaker Houghton", any security holder of Quaker Houghton, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (4) to this Form 4. Read SEC document |
| August 11, 2020 Filed Aug 12, 2020 20:30 UTC |
BERQUIST JOSEPH ASVP, GL SPEC BUS & CSO
|
SaleCommon Stock | 1,188 | $201.75 | $239,679.00 |
DisclosureSEC source: 0001209191-20-046372 · doc4.xml · nonDerivative · entry 5 BERQUIST JOSEPH A · CIK 0001487224 · SVP, GL SPEC BUS & CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,987 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $201.14 to $202.13, inclusive. The reporting person undertakes to provide to Quaker Chemical Corporation, d/b/a "Quaker Houghton", any security holder of Quaker Houghton, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (3) to this Form 4. Read SEC document |
| August 11, 2020 Filed Aug 12, 2020 20:30 UTC |
BERQUIST JOSEPH ASVP, GL SPEC BUS & CSO
|
Exercise / conversionCommon Stock | 1,660 | $151.75 | $251,905.00 |
DisclosureSEC source: 0001209191-20-046372 · doc4.xml · nonDerivative · entry 4 BERQUIST JOSEPH A · CIK 0001487224 · SVP, GL SPEC BUS & CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,175 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 11, 2020 Filed Aug 12, 2020 20:30 UTC |
BERQUIST JOSEPH ASVP, GL SPEC BUS & CSO
|
SaleCommon Stock | 200 | $202.61 | $40,522.00 |
DisclosureSEC source: 0001209191-20-046372 · doc4.xml · nonDerivative · entry 3 BERQUIST JOSEPH A · CIK 0001487224 · SVP, GL SPEC BUS & CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,515 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $202.575 to $202.635, inclusive. The reporting person undertakes to provide to Quaker Chemical Corporation, d/b/a "Quaker Houghton", any security holder of Quaker Houghton, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4. Read SEC document |
| August 11, 2020 Filed Aug 12, 2020 20:30 UTC |
BERQUIST JOSEPH ASVP, GL SPEC BUS & CSO
|
SaleCommon Stock | 1,988 | $201.97 | $401,516.36 |
DisclosureSEC source: 0001209191-20-046372 · doc4.xml · nonDerivative · entry 2 BERQUIST JOSEPH A · CIK 0001487224 · SVP, GL SPEC BUS & CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,715 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $201.42 to $202.41, inclusive. The reporting person undertakes to provide to Quaker Chemical Corporation, d/b/a "Quaker Houghton", any security holder of Quaker Houghton, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4. Read SEC document |
| August 11, 2020 Filed Aug 12, 2020 20:30 UTC |
BERQUIST JOSEPH ASVP, GL SPEC BUS & CSO
|
Exercise / conversionCommon Stock | 2,188 | $134.60 | $294,504.80 |
DisclosureSEC source: 0001209191-20-046372 · doc4.xml · nonDerivative · entry 1 BERQUIST JOSEPH A · CIK 0001487224 · SVP, GL SPEC BUS & CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,703 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 11, 2020 Filed Aug 13, 2020 20:18 UTC |
Laininger DieterSVP, Managing Director - APAC
|
SaleCommon Stock | 3,000 | $201.00 | $603,000.00 |
DisclosureSEC source: 0001209191-20-046600 · doc4.xml · nonDerivative · entry 1 Laininger Dieter · CIK 0001523157 · SVP, Managing Director - APAC 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,368 F1 · balance_after: Includes 3 shares acquired in Company's Dividend Reinvestment Plan on July 31, 2020. Read SEC document |
| August 10, 2020 Filed Aug 12, 2020 20:21 UTC |
Shannon Michael JDirector
|
SaleCommon Stock | 192 | $201.71 | $38,728.32 |
DisclosureSEC source: 0001209191-20-046356 · doc4.xml · nonDerivative · entry 2 Shannon Michael J · CIK 0001352163 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,493 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $201.67 to $201.74, inclusive. The reporting person undertakes to provide to Quaker Chemical Corporation, d/b/a "Quaker Houghton", any security holder of Quaker Houghton, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4. Read SEC document |
| August 10, 2020 Filed Aug 12, 2020 20:21 UTC |
Shannon Michael JDirector
|
SaleCommon Stock | 2,702 | $201.07 | $543,291.14 |
DisclosureSEC source: 0001209191-20-046356 · doc4.xml · nonDerivative · entry 1 Shannon Michael J · CIK 0001352163 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,685 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $200.60 to $201.56, inclusive. The reporting person undertakes to provide to Quaker Chemical Corporation, d/b/a "Quaker Houghton", any security holder of Quaker Houghton, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4. Read SEC document |
| August 10, 2020 Filed Oct 13, 2020 20:22 UTC |
BARRY MICHAEL FDirector · Chairman, CEO and President
|
GiftCommon Stock | 5,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-054635 · doc4.xml · nonDerivative · entry 1 BARRY MICHAEL F · CIK 0001238141 · Director · Chairman, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 120,778 Read SEC document |
| August 01, 2020 Filed Aug 4, 2020 20:20 UTC |
HOSTETTER SHANEVP, Finance and CAO
|
Tax withholdingCommon Stock | 69 | $194.00 | $13,386.00 |
DisclosureSEC source: 0001209191-20-044678 · doc4.xml · nonDerivative · entry 1 HOSTETTER SHANE · CIK 0001576686 · VP, Finance and CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,438 F1 · shares: Shares surrendered by reporting person to satisfy withholding tax obligation upon partial vesting of restricted stock granted on August 15, 2019 under the Company's 2016 Long-Term Performance Incentive Plan. Read SEC document |
| July 22, 2020 Filed Jul 22, 2020 21:38 UTC |
BARRY MICHAEL FDirector · Chairman, CEO and President
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 7,065 | $0.00 Strike: $154.92 | $0.00 |
DisclosureSEC source: 0001209191-20-043356 · doc4.xml · derivative · entry 10 BARRY MICHAEL F · CIK 0001238141 · Director · Chairman, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,128 Underlying: Common Stock · 7,065 shares Expires 2026-02-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: The options for this grant vest in three annual installments: 7,065 shares on February 25, 2020; 7,064 shares on February 25, 2021; and 7,064 shares on February 25, 2022. Read SEC document |
| July 22, 2020 Filed Jul 22, 2020 21:38 UTC |
BARRY MICHAEL FDirector · Chairman, CEO and President
|
Tax withholdingCommon Stock | 5,306 | $206.23 | $1,094,256.38 |
DisclosureSEC source: 0001209191-20-043356 · doc4.xml · nonDerivative · entry 7 BARRY MICHAEL F · CIK 0001238141 · Director · Chairman, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 125,778 Read SEC document |
| July 22, 2020 Filed Jul 22, 2020 21:38 UTC |
BARRY MICHAEL FDirector · Chairman, CEO and President
|
Exercise / conversionCommon Stock | 7,065 | $154.92 | $1,094,509.80 |
DisclosureSEC source: 0001209191-20-043356 · doc4.xml · nonDerivative · entry 6 BARRY MICHAEL F · CIK 0001238141 · Director · Chairman, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 131,084 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 20, 2020 Filed Jul 22, 2020 21:38 UTC |
BARRY MICHAEL FDirector · Chairman, CEO and President
|
SaleCommon Stock | 100 | $200.95 | $20,095.00 |
DisclosureSEC source: 0001209191-20-043356 · doc4.xml · nonDerivative · entry 5 BARRY MICHAEL F · CIK 0001238141 · Director · Chairman, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 124,019 F1 · kind: The sale of shares reported for this transaction was effected pursuant to a Rule 10b5-1 Plan entered into by reporting person on May 28, 2020. Read SEC document |
| July 20, 2020 Filed Jul 22, 2020 21:38 UTC |
BARRY MICHAEL FDirector · Chairman, CEO and President
|
SaleCommon Stock | 3,600 | $200.10 | $720,360.00 |
DisclosureSEC source: 0001209191-20-043356 · doc4.xml · nonDerivative · entry 4 BARRY MICHAEL F · CIK 0001238141 · Director · Chairman, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 124,119 F1 · kind: The sale of shares reported for this transaction was effected pursuant to a Rule 10b5-1 Plan entered into by reporting person on May 28, 2020. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $199.67 to $200.51, inclusive. The reporting person undertakes to provide to Quaker Chemical Corporation, d/b/a "Quaker Houghton", any security holder of Quaker Houghton, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (5) to this Form 4. Read SEC document |
| July 20, 2020 Filed Jul 22, 2020 21:38 UTC |
BARRY MICHAEL FDirector · Chairman, CEO and President
|
SaleCommon Stock | 4,406 | $199.05 | $877,014.30 |
DisclosureSEC source: 0001209191-20-043356 · doc4.xml · nonDerivative · entry 3 BARRY MICHAEL F · CIK 0001238141 · Director · Chairman, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 127,719 F1 · kind: The sale of shares reported for this transaction was effected pursuant to a Rule 10b5-1 Plan entered into by reporting person on May 28, 2020. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $198.63 to $199.46, inclusive. The reporting person undertakes to provide to Quaker Chemical Corporation, d/b/a "Quaker Houghton", any security holder of Quaker Houghton, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (4) to this Form 4. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.